QUR’ON QIROATINING LINGVISTIK TA’SIRI
Ijtimoiy-gumanitar sohada ilmiy-innovatsion tadqiqotlar · 05.10.2026 · 3 (10) · 332-334
DOI: 10.67227/sgf1cc02 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ijtimoiy-gumanitar sohada ilmiy-innovatsion tadqiqotlar, online erschienen am 05.10.2026. Verfasst von Nizomiddin Quldashev und 1 weiteren Autor:innen.
Abstract (Originalsprache)
This scientific article examines Qur’anic recitation (Qira’at) from the perspective of modern linguistic approaches and phonetic research. The study analyzes the articulation of sounds in Qur’anic recitation, the characteristics of makhraj (places of articulation) and sifat al-huruf (phonetic attributes of letters), the phenomenon of madd (sound prolongation), and sound duration using approaches from modern articulatory and acoustic phonetics. Furthermore, the role of prosodic features such as waqf and ibtida (pausing and resuming recitation), intonation, and rhythm in the phonetic and semantic organization of Qur’anic recitation is examined. The article also explores the possibilities of describing traditional Tajweed and Qira’at principles through modern linguistic terminology and acoustic analysis tools. The findings demonstrate that Qur’anic recitation can be studied as a complex linguistic phenomenon characterized by the interrelationship of phonetic, phonological, and prosodic aspects.
Zitieren
APA
Quldashev, N., & Vahobova, O. (2026). QUR’ON QIROATINING LINGVISTIK TA’SIRI. Ijtimoiy-gumanitar sohada ilmiy-innovatsion tadqiqotlar, 3(10), 332-334. https://doi.org/10.67227/sgf1cc02
Vancouver
Quldashev N, Vahobova O. QUR’ON QIROATINING LINGVISTIK TA’SIRI. Ijtimoiy-gumanitar sohada ilmiy-innovatsion tadqiqotlar. 2026;3(10):332-334. doi:10.67227/sgf1cc02
BibTeX
@article{Quldashev2026,
author = {Quldashev, Nizomiddin and Vahobova, Oyshaxon},
title = {QUR’ON QIROATINING LINGVISTIK TA’SIRI},
journal = {Ijtimoiy-gumanitar sohada ilmiy-innovatsion tadqiqotlar},
year = {2026},
volume = {3},
number = {10},
pages = {332--334},
doi = {10.67227/sgf1cc02}
}
EUVIMED